The production of biological products in biopharmaceutical manufacturing involves significant risks of viral contamination from human and animal-derived material, and ensuring the viral safety of biologics manufacturing is a critical concern for the industry.

The study highlights the importance of adopting new technologies and practices to enhance viral detection and removal, thus safeguarding the integrity of biologic products. Given the significant risks and potential consequences of viral contamination in biopharmaceutical manufacturing, it is highly worthwhile for industry stakeholders to consider adopting the most effective viral safety measures available.

Learn about the authors below.